According to the results of tests conducted on A2780/CP70 ovarian cancer cells, KEM significantly increased the cleavage of PARP-1 and the activity of caspase-3/7, as well as the activity of caspase-8 and -9 common to both pathways. The gene discussed is CASP8; the disease is ovarian carcinoma.